Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.

Mutations in transmembrane protease, serine 6 (TMPRSS6), encoding matriptase-2, are responsible for the familial anemia disorder iron-refractory iron deficiency anemia (IRIDA). Patients with IRIDA have inappropriately elevated levels of the iron regulatory hormone hepcidin, suggesting that TMPRSS6 is involved in negatively regulating hepcidin expression. Hepcidin is positively regulated by iron via the bone morphogenetic protein (BMP)-SMAD signaling pathway. In this study, we investigated whether BMP6 and iron also regulate TMPRSS6 expression. Here we demonstrate that, in vitro, treatment with BMP6 stimulates TMPRSS6 expression at the mRNA and protein levels and leads to an increase in matriptase-2 activity. Moreover, we identify that inhibitor of DNA binding 1 is the key element of the BMP-SMAD pathway to regulate TMPRSS6 expression in response to BMP6 treatment. Finally, we show that, in mice, Tmprss6 mRNA expression is stimulated by chronic iron treatment or BMP6 injection and is blocked by injection of neutralizing antibody against BMP6. Our results indicate that BMP6 and iron not only induce hepcidin expression but also induce TMPRSS6, a negative regulator of hepcidin expression. Modulation of TMPRSS6 expression could serve as a negative feedback inhibitor to avoid excessive hepcidin increases by iron to help maintain tight homeostatic balance of systemic iron levels.

[1]  C. Hong,et al.  The bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[2]  Paolo Ventura,et al.  Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)‐SMAD signaling pathway in mice , 2011, Hepatology.

[3]  H. Tsukamoto,et al.  Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. , 2011, Blood.

[4]  S. Arber,et al.  Dragon (Repulsive Guidance Molecule b) Inhibits IL-6 Expression in Macrophages , 2011, The Journal of Immunology.

[5]  P. Ratcliffe,et al.  Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors , 2010, The Journal of Biological Chemistry.

[6]  C. Enns,et al.  Matriptase-2- and Proprotein Convertase-cleaved Forms of Hemojuvelin Have Different Roles in the Down-regulation of Hepcidin Expression* , 2010, The Journal of Biological Chemistry.

[7]  J. Truksa,et al.  EPO‐mediated reduction in Hamp expression in vivo corrects iron deficiency anaemia in TMPRSS6 deficiency , 2010, British journal of haematology.

[8]  M. Gütschow,et al.  Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface. , 2010, The Biochemical journal.

[9]  J. Bajorath,et al.  Identification of the first low-molecular-weight inhibitors of matriptase-2. , 2010, Journal of medicinal chemistry.

[10]  Michael Boutros,et al.  SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. , 2010, Blood.

[11]  Toshiko Tanaka,et al.  A genome-wide association analysis of serum iron concentrations. , 2010, Blood.

[12]  C. Hong,et al.  Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. , 2009, The Journal of clinical investigation.

[13]  Gonçalo Abecasis,et al.  Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels , 2009, Nature Genetics.

[14]  Ian H. Frazer,et al.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume , 2009, Nature Genetics.

[15]  Christian Gieger,et al.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.

[16]  Paolo Ventura,et al.  Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. , 2009, Gastroenterology.

[17]  Herbert Y. Lin,et al.  The RGM/DRAGON family of BMP co-receptors. , 2009, Cytokine & growth factor reviews.

[18]  V. Quesada,et al.  Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. , 2009, Human molecular genetics.

[19]  M. Roth,et al.  BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. , 2009, Blood.

[20]  R. Leduc,et al.  Probing the substrate specificities of matriptase, matriptase‐2, hepsin and DESC1 with internally quenched fluorescent peptides , 2009, The FEBS journal.

[21]  M. Roth,et al.  Lack of the bone morphogenetic protein BMP6 induces massive iron overload , 2009, Nature Genetics.

[22]  Yin Xia,et al.  BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism , 2009, Nature Genetics.

[23]  Matthias W. Hentze,et al.  Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD , 2009, Journal of Molecular Medicine.

[24]  Jerry Kaplan,et al.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.

[25]  C. López-Otín,et al.  Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. , 2008, Blood.

[26]  C. Beaumont,et al.  Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. , 2008, Blood.

[27]  Jean Mosser,et al.  Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. , 2008, Blood.

[28]  Randall T Peterson,et al.  Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[29]  B. Beutler,et al.  The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency , 2008, Science.

[30]  N. Andrews,et al.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.

[31]  Charles C Hong,et al.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.

[32]  Yin Xia,et al.  Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.

[33]  P. Dijke,et al.  Negative regulation of TGF-β receptor/Smad signal transduction , 2007 .

[34]  P. ten Dijke,et al.  Negative regulation of TGF-beta receptor/Smad signal transduction. , 2007, Current opinion in cell biology.

[35]  S. Vukicevic,et al.  Systemically Administered Bone Morphogenetic Protein-6 Restores Bone in Aged Ovariectomized Rats by Increasing Bone Formation and Suppressing Bone Resorption* , 2006, Journal of Biological Chemistry.

[36]  S. Vaulont,et al.  Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. , 2006, Blood.

[37]  G. Anderson,et al.  Iron metabolism meets signal transduction , 2006, Nature Genetics.

[38]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[39]  Xiaoling Xu,et al.  A Role of Smad4 in Iron Metabolism through the Positive Regulation of Hepcidin Expression , 2022 .

[40]  S. Arber,et al.  Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. , 2005, The Journal of clinical investigation.

[41]  G. Pinkus,et al.  A mouse model of juvenile hemochromatosis. , 2005, The Journal of clinical investigation.

[42]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[43]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[44]  Marie-Pierre Dubé,et al.  Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.

[45]  R. Benezra,et al.  Id proteins in development, cell cycle and cancer. , 2003, Trends in cell biology.

[46]  L. Campagnolo,et al.  Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. , 2003, The Biochemical journal.

[47]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[48]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[49]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[50]  V. Quesada,et al.  Matriptase-2, a Membrane-bound Mosaic Serine Proteinase Predominantly Expressed in Human Liver and Showing Degrading Activity against Extracellular Matrix Proteins* , 2002, The Journal of Biological Chemistry.

[51]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[52]  N. Takahashi,et al.  Identification of a BMP‐responsive element in Id1, the gene for inhibition of myogenesis , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[53]  H. Axelson,et al.  Modulation of Basic Helix-Loop-Helix Transcription Complex Formation by Id Proteins during Neuronal Differentiation* , 2002, The Journal of Biological Chemistry.

[54]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.